V-Y Nasolabial Flap for Reconstruction after Basal Cell Carcinoma Excision

Sarah Anjani Putri, Yugos Juli Fitra, Kurniadi -

Abstract

Background: Basal cell carcinoma (BCC) is the most common malignancy worldwide.1 It is usually found in older populations, particularly those exposed to ultraviolet radiation. It is almost always curable when detected and treated early. Surgery remains the cornerstone of BCC treatment; but standard excision results in defects requiring reconstruction. For smaller defects, the V-Y flap is a popular option due to its advantages. Case : A 33 year-old male with a blackened lesion on the left vermillion border of the upper lip with a diameter of 2 cm since 3 months, suspected as basal cell carcinoma. The patient underwent wide excision and the defect was reconstructed using a V-Y flap. Conclusion : Wide local excision is a treatment of choice for BCC to ensure clear margins, preventing further local recurrence and distant metastasis. V-Y advancement flap is preferable for the reconstruction of small to medium size facial defects with less scarring and better aesthetic results.

Latar belakang: Karsinoma sel basal (KSB) adalah keganasan yang paling sering ditemukan di seluruh dunia; biasanya pada populasi usia lanjut, khususnya yang terpapar radiasi sinar ultraviolet. KSB hampir selalu dapat disembuhkan apabila terdeteksi dan diberi tatalaksana dini. Pembedahan tetap merupakan landasan tatalaksana KSB, akan tetapi eksisi standar akan meninggalkan defek yang membutuhkan rekonstruksi. Untuk defek yang lebih kecil, flap V-Y merupakan pilihan populer. Kasus: Seorang laki-laki usia 33 tahun dengan lesi berwarna hitam di batas vermilion kiri di atas bibir dengan diameter 2 cm sejak 3 bulan, diduga karsinoma sel basal. Pasien menjalani operasi eksisi luas dan defeknya direkonstruksi menggunakan flap V-Y. Simpulan: Eksisi lokal luas adalah tatalaksana pilihan KBS untuk memastikan margin yang jelas, mencegah rekurensi lokal, dan metastatis jauh. Flap V-Y lebih dipilih untuk defek wajah dengan ukuran kecil hingga sedang karena bekas luka yang lebih kecil dan secara estetika lebih baik.

Full Text:

PDF

References

Wilvestra S, Lestari S, Asri E. Studi Retrospektif Kanker Kulit di Poliklinik Ilmu Kesehatan. J Kes Andalas. 2018;7(3):47–9.

Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, et al. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019;80(2):303–17.

Perry DM, Barton V, Alberg AJ. Epidemiology of Keratinocyte Carcinoma. Vol. 6. Curr Dermatol Rep. 2017;1:161–8.

Bader RS. Basal Cell Carcinoma Clinical Presentation [Internet]. Medscape. 2020. Available from: https://emedicine.medscape.com/article/276624-clinical

Wong CSM, Strange RC, Lear JT. Basal cell carcinoma. BMJ (Clinical Research ed). 2003;327(7418):794–8.

Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, McLean DI, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol. 1995;131(2):157–63.

Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88(2):167–79.

Zanetti R, Rosso S, C Martinez, Nieto A, Miranda A, Mercier M. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-casecontrol study. Br J Cancer. 2006;95(5):743–51.

Dourmishev LA, Rusinova D, Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J. 2013;4(1):12–7.

Soyer H, Rigel D, Wurm E. Actinic Keratosis, Basal Cell Carcinoma and Squamous Cell Carcinoma. In: Bolognia J, Jorizzo J, Schaffer J, eds. Dermatology 2. 3rd ed. Saunders; 2012. pp. 1773–93.

Mackiewicz-Wysocka M, Bowszyc-Dmochowska M, Strzelecka-Węklar D, Dańczak-Pazdrowska A, Adamski Z. Basal cell carcinoma - diagnosis. Contemporary Oncol (Poznan, Poland) 2013;17(4):337–42.

Choi JH, Kim YJ, Kim H, Nam SH, Choi YW. Distribution of Basal cell carcinoma and squamous cell carcinoma by facial esthetic unit. Arch Plastic Surg. 2013;40(4):387–91.

Rao JK, Shende KS. Overview of Local Flaps of the Face for Reconstruction of Cutaneous Malignancies: Single Institutional Experience of Seventy Cases. J Cutaneous Aesthetic Surg. 2016;9(4):220–5.

Drucker A, Adam G, Rofeberg V, Gazula A, Smith B, Moustafa F, et al. Treatments of Primary Basal Cell Carcinoma of the Skin: A Systematic Review and Network Meta-analysis. Ann Intern Med. 2018;169(7):456–66.

Hajdarbegovic E, van der Leest R, Munte K, Thio H, Neumann H. Neoplasms of the facial skin. Clin Plastic Surg. 2009;36:319–34.

Bichakjian C, Armstrong A, Baum C, Bordeaux JS, Brown M, Busam KJ, et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol. 2018;78(3):540–59.

McDaniel B, Badri T. Basal Cell Carcinoma [Internet]. StatPearls Publishing. 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482439/

Bath-Hextall F, Ozolins M, Armstrong S. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol. 2014;15(1):96–105.

Chlebicka I, Rygal A, Stefaniak AA, Szepietowski JC. Basal cell carcinoma—Primary closure of moderate defect of mid forehead. Dermatol Ther. 2020;33.

Han SK, Yoon WY, Jeong SH, Kim WK. Facial dermis grafts after removal of basal cell carcinomas. J Craniofacial Surg. 2012;23(6):1895–7.

Refbacks

  • There are currently no refbacks.